Deep learning radiomics model based on PET/CT predicts PD-L1 expression in non-small cell lung cancer

Bo Li; Jie Su; Kai Liu; Chunfeng Hu

doi:10.1016/j.ejro.2024.100549

Deep learning radiomics model based on PET/CT predicts PD-L1 expression in non-small cell lung cancer

Eur J Radiol Open. 2024 Jan 19:12:100549. doi: 10.1016/j.ejro.2024.100549. eCollection 2024 Jun.

Authors

Bo Li¹, Jie Su¹, Kai Liu¹, Chunfeng Hu¹

Affiliation

¹ Department of Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, China.

Abstract

Purpose: Programmed cell death protein-1 ligand (PD-L1) is an important prognostic predictor for immunotherapy of non-small cell lung cancer (NSCLC). This study aimed to develop a non-invasive deep learning and radiomics model based on positron emission tomography and computed tomography (PET/CT) to predict PD-L1 expression in NSCLC.

Methods: A total of 136 patients with NSCLC between January 2021 and September 2022 were enrolled in this study. The patients were randomly divided into the training dataset and the validation dataset in a ratio of 7:3. Radiomics feature and deep learning feature were extracted from their PET/CT images. The Mann-whitney U-test, Least Absolute Shrinkage and Selection Operator algorithm and Spearman correlation analysis were used to select the top significant features. Then we developed a radiomics model, a deep learning model, and a fusion model based on the selected features. The performance of three models were compared by the area under the curve (AUC), sensitivity, specificity, accuracy, positive predictive value, and negative predictive value.

Results: Of the patients, 42 patients were PD-L1 negative and 94 patients were PD-L1 positive. A total of 2446 radiomics features and 4096 deep learning features were extracted per patient. In the training dataset, the fusion model achieved a highest AUC (0.954, 95% confident internal [CI]: 0.890-0.986) compared with the radiomics model (0.829, 95%CI: 0.738-0.898) and the deep learning model (0.935, 95%CI: 0.865-0.975). In the validation dataset, the AUC of the fusion model (0.910, 95% CI: 0.779-0.977) was also higher than that of the radiomics model (0.785, 95% CI: 0.628-0.897) and the deep learning model (0.867, 95% CI: 0.724-0.952).

Conclusion: The PET/CT-based deep learning radiomics model can predict the PD-L1 expression accurately in NSCLC patients, and provides a non-invasive tool for clinicians to select positive PD-L1 patients.

Keywords: Deep learning; Machine learning; Non-small cell lung cancer; PD-L1; PET/CT; Radiomics.